State NJ
Clinical Trials in New Jersey
New Jersey is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Jersey and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 247 actively recruiting studies with New Jersey sites out of 247 registered in total. The busiest research areas in New Jersey are Breast Cancer, Multiple Myeloma, Endometrial Cancer. Leading sponsors running trials in the state include Memorial Sloan Kettering Cancer Center, Rutgers, The State University of New Jersey, AstraZeneca. By stage, New Jersey trials break down as Phase 1 (46), Phase 2 (74), Phase 3 (77), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Jersey
Frequently Asked Questions — Clinical Trials in New Jersey
How many clinical trials are currently recruiting in New Jersey?
ClinicalMetric currently tracks 247 actively recruiting clinical trials with at least one location in New Jersey. The total number of registered studies—including active but not currently enrolling trials—is 247. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Jersey?
New Jersey hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Jersey serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Jersey?
To join a clinical trial in New Jersey, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Jersey maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Jersey
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
1,160 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07594782 N/A
Recruiting
ED Medicaid Support
Condition
Pediatric Uninsured Emergency Visits
Enrollment
180 pts
Location
United States
Sponsor
Hackensack Meridian Health
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT07529717 Phase 1, Phase 2
Recruiting
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostat...
Condition
Metastatic Prostate Cancer
Enrollment
42 pts
Location
United States, Australia, South Korea
Sponsor
AstraZeneca
NCT06854978 N/A
Recruiting
R3THA Rehabilitation Feasibility and Usability Study
Condition
Stroke
Enrollment
10 pts
Location
United States
Sponsor
Kessler Foundation
NCT06004414 N/A
Recruiting
SilverCloud as a School-Based Intervention for Vulnerable Youth
Condition
Depression
Enrollment
120 pts
Location
United States
Sponsor
NYU Langone Health
NCT06073626 N/A
Recruiting
Addressing Genomic Disparities in Cancer Survivors
Condition
Hereditary Cancer
Enrollment
428 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06546085 N/A
Recruiting
Extracellular Vesicles, Insulin Action, and Exercise
Condition
Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Rutgers, The State University
NCT07091084 N/A
Recruiting
A Study of Herbal Supplements in Cancer Survivors With Constipation
Condition
Constipation
Enrollment
70 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05721781 N/A
Recruiting
Reducing Risk for Infective Endocarditis
Condition
Bacteremia
Enrollment
320 pts
Location
United States
Sponsor
Wake Forest University Health
NCT07105709 Phase 2
Recruiting
Open-label Extension Study in Participants With Early Alzheimer's Disease
Condition
Alzheimer's Disease
Enrollment
220 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT03378557 N/A
Recruiting
Periprosthetic Fracture Registry (PPFx)
Condition
Periprosthetic Fractures
Enrollment
600 pts
Location
United States, Belgium, Colombia
Sponsor
AO Innovation Translation Cent
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
NCT05559164 Phase 2
Recruiting
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Condition
Cardiac Toxicity
Enrollment
60 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06388967 N/A
Recruiting
Pancreatic Cancer Detection Consortium
Condition
Pancreatic Cancer
Enrollment
2,000 pts
Location
United States, Japan, South Korea
Sponsor
City of Hope Medical Center
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rea...
Condition
Acute Myeloid Leukemia
Enrollment
447 pts
Location
United States, Australia, Canada
Sponsor
Syndax Pharmaceuticals
NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT02860364 N/A
Recruiting
Comparing Hypothermic Temperatures During Hemiarch Surgery
Condition
Thoracic Aortic Disease
Enrollment
282 pts
Location
United States, Canada
Sponsor
Ottawa Heart Institute Researc
NCT07675499 Phase 2, Phase 3
Recruiting
Exercise and Intranasal Insulin in Type 2 Diabetes
Condition
Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
NCT04372277 Phase 4
Recruiting
Taltz in Combination With Enstilar for Psoriasis
Condition
Psoriasis
Enrollment
25 pts
Location
United States
Sponsor
Psoriasis Treatment Center of
NCT05877599 Phase 1
Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Posi...
Condition
Non-small Cell Lung Cancer
Enrollment
45 pts
Location
United States
Sponsor
AstraZeneca
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology